HNRNPK and hepatocellular carcinoma: PSTAR enhances the SUMOylation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) and promotes its interaction with p53, thereby leading to p53 transactivation and repressing HCC tumorigenicity.7